Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study.

Waddington, Claire S; Walker, W T; Oeser, C; Reiner, A; John, T; Wilkins, S; Casey, M; Eccleston, P E; Allen, R J; Okike, I; Ladhani, S; Sheasby, E; Hoschler, K; Andrews, N; Waight, P; Collinson, A C; Heath, P T; Finn, A; Faust, S N; Snape, M D; Miller, E; Pollard, A J

Waddington, Claire S; Walker, W T; Oeser, C; Reiner, A; John, T; Wilkins, S; Casey, M; Eccleston, P E; Allen, R J; Okike, I; Ladhani, S; Sheasby, E; Hoschler, K; Andrews, N; Waight, P; Collinson, A C; Heath, P T; Finn, A; Faust, S N; Snape, M D; Miller, E; Pollard, A J.

Affiliation

Waddington CS; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford OX3 7LJ. claire.waddington@paediatrics.ox.ac.uk

BMJ ; 340: c2649, 2010 May 27.

Article in En | MEDLINE | ID: mdl-20508026

Subject(s)

Adjuvants, Immunologic/adverse effects; Influenza A Virus, H1N1 Subtype/immunology; Influenza Vaccines/adverse effects; Influenza, Human/prevention & control; Virion/immunology; Adolescent; Child; Child, Preschool; Drug Combinations; Female; Hemagglutination Inhibition Tests; Humans; Infant; Influenza Vaccines/immunology; Male; Polysorbates/adverse effects; Squalene/adverse effects; Squalene/immunology; alpha-Tocopherol/adverse effects; alpha-Tocopherol/immunology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Virion / Influenza Vaccines / Adjuvants, Immunologic / Influenza, Human / Influenza A Virus, H1N1 Subtype Type of study: Clinical_trials / Guideline Language: En Journal: BMJ Year: 2010 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google